[HTML][HTML] Recurrence of papillary thyroid cancer after optimized surgery

CS Grant - Gland surgery, 2015 - ncbi.nlm.nih.gov
Recurrence of papillary thyroid cancer (PTC) after optimized surgery requires a full
understanding of the disease, especially as it has changed in the last 15 years, what …

An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer

IJ Nixon, LY Wang, JC Migliacci, A Eskander… - Thyroid, 2016 - liebertpub.com
Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Percutaneous ethanol injection vs reoperation for locally recurrent papillary thyroid cancer: a systematic review and pooled analysis

TE Fontenot, A Deniwar, P Bhatia… - … –Head & Neck …, 2015 - jamanetwork.com
Importance Reoperation for recurrent papillary thyroid cancer (PTC) can be associated with
a high rate of complications and failure to provide lasting remission. Percutaneous ethanol …

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis

FH Liu, SF Kuo, C Hsueh, TC Chao… - Journal of surgical …, 2015 - Wiley Online Library
Background and Objectives: The purpose of this study was to retrospectively analyze the
features of patients with papillary thyroid carcinoma (PTC) presenting with neck lymph node …

Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection

IJ Nixon, LY Wang, I Ganly, SG Patel… - Journal of British …, 2016 - academic.oup.com
Background The role of prophylactic central neck dissection (CND) in the management of
papillary thyroid cancer (PTC) is controversial. This report describes outcomes of an …

Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors

HR Nieto, CEM Thornton, K Brookes… - The Journal of …, 2022 - academic.oup.com
Context Thyroid cancer recurrence is associated with increased mortality and adverse
outcomes. Recurrence risk is currently predicted using clinical tools, often restaging patients …

Disparities in initial thyroid cancer care by hospital treatment volume: analysis of 52,599 cases in California

H Huston-Paterson, Y Mao, CH Tseng, J Kim, MW Yeh… - Thyroid, 2023 - liebertpub.com
Background: Racially minoritized patients with thyroid cancer are less likely to receive high-
quality and guideline-concordant care. Inaccessibility of high-volume centers may contribute …

Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management

N Chéreau, C Buffet, C Trésallet, F Tissier, L Leenhardt… - Surgery, 2016 - Elsevier
Background Lateral neck lymph node (LN) metastases (N1b) have been identified as
independent risk factors of recurrence in patients with papillary thyroid carcinoma (PTC) …

Circ_0058124 upregulates MAPK1 expression to promote proliferation, metastasis and metabolic abilities in thyroid cancer through sponging miR-940

D Sun, L Chen, H Lv, Y Gao, X Liu… - OncoTargets and …, 2020 - Taylor & Francis
Background Thyroid cancer (TC) is an endocrine disease, and its progression is regulated
by many factors, including circular RNAs (circRNAs). However, as a new circRNA, the role of …

[HTML][HTML] Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer

Z Chen, ML Guo, YY Li, K Yan, L Li, F Shen… - Frontiers in …, 2022 - frontiersin.org
Background Thyroid tissue has a special immune microenvironment that is not well
characterized. Whether immune cells have a prognostic value in the recurrence of papillary …